Budesonide, a beta-adreno-receptor agonist, is comparable to corticost
eroid in the treatment of patients with inflammatory bowel disease wit
h the advantage of minimal side effect. Although the immunomodulatory
effects of budesonide on the circulatory and respiratory mucosal immun
e system have been reported, its effect on the human gut immune system
has not been published. In this study, the effect of budesonide on th
e human gut immune system was compared to methyl-prednisolone. The cel
lular immune function was measured in-vitro by DNA synthesis, ornithin
e decarboxylase (ODC) activity and TNFalpha secretion. We found that b
oth drugs have a comparable inhibitory effect on DNA synthesis, ODC ac
tivity and suppression of TNFalpha secretion. Exogenous addition of IL
-2, did not restore the antiproliferative effect of both drugs. We con
clude that budesonide has a comparative suppressive effect to methyl-p
rednisolone on the gut immune system which is not related to IL-2 secr
etion. The antiproliferative response may explain the therapeutic effe
ct of budesonide on patients with inflammatory bowel disease. (C) 1998
Elsevier Science B.V.